Raymond James & Associates’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $32.4K | Sell |
|
|||||
|
2024
Q2 | $40.2K | Sell |
|
|||||
|
2024
Q1 | $61.9K | Buy |
|
|||||
|
2023
Q4 | $70.7K | Sell |
|
|||||
|
2023
Q3 | $74.2K | Sell |
|
|||||
|
2023
Q2 | $341K | Buy |
|
|||||
|
2023
Q1 | $355K | Buy |
|
|||||
|
2022
Q4 | $207K | Sell |
|
|||||
|
2022
Q3 | $222K | Buy |
|
|||||
|
2022
Q2 | $194K | Buy |
|
|||||
|
2022
Q1 | $156K | Sell |
|
|||||
|
2021
Q4 | $1.04M | Sell |
|
|||||
|
2021
Q3 | $2.53M | Buy |
|
|||||
|
2021
Q2 | $2.62M | Buy |
|
|||||
|
2021
Q1 | $2.48M | Buy |
|